BTMD MEXC RealStocks
Own real BTMD shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:59:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Biote Corp. (BTMD) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $0.89, with a market capitalization of $25.97M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.88 to $2.90. This page covers its latest market performance, valuation, price trends and company information.
$25.97M | |
$1.01 | |
$1.01 | |
$0.88 | |
$0.99 | |
80.94K | |
184.67K | |
-- | |
$2.90 | |
$0.88 | |
4.36% | |
2026-09-30 |
Biote Corp. (BTMD) last closed at $0.89 as of 2026-11-18 23:30:00, down 12.18% ($0.12) from the previous close of $0.99.
During the latest regular trading session, BTMD traded between $0.88 and $1.01, with a volume of 80.94K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Biote Corp. (BTMD) moved from $1.11 to $0.89, representing a decline of 20.09% ($0.22).
The stock traded between $0.88 and $1.14 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 75.92 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.3%
BTMD is currently trading at $0.89, placing it 0.3% of the way from its 52-week low of $0.88 to its 52-week high of $2.90. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 223 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Biote Corp. (BTMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to BTMD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between BTMD shares and USD.
BTMD Shares to USD
1.00 BTMD shares = 0.887 USD
Calculations are estimates based on the latest available price and are for reference only.